<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03656016</url>
  </required_header>
  <id_info>
    <org_study_id>CSFFPCMRI</org_study_id>
    <nct_id>NCT03656016</nct_id>
  </id_info>
  <brief_title>Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique.</brief_title>
  <official_title>Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebrospinal fluid is a clear, colorless fluid that circulates in the cranial and spinal
      subarachnoid spaces, located between the pia and arachnoid matters. It is mainly produced by
      the choroid plexus, while lesser amount produced by the ependymal cells lining the
      ventricles. Its function includes cushioning and lubrication of the central nervous system,
      circulation of nutrients and waste collection providing basic mechanical and immunological
      protection to the brain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are several disorders such as communicating and non- communicating hydrocephalus,
      normal pressure hydrocephalus, cystic cerebrospinal fluid collections, Chiari malformation,
      syringomyelic cyst and arachnoid cyst that can change the cerebrospinal fluid dynamics.

      Rapid advances in imaging techniques have remarkably improved the diagnosis and treatment of
      these disorders.

      Phase contrast magnetic resonance imaging is a rapid, simple and non-invasive technique which
      is sensitive to even small cerebrospinal fluid flows, and can be used to evaluate
      cerebrospinal fluid flow both qualitatively and quantitatively. Cine phase contrast magnetic
      resonance images show cerebrospinal fluid flow in a dynamic, more easily appreciable, and in
      a more pleasing manner, allowing the delineation of obstruction, if present, along the
      portions of cerebrospinal fluid pathway where obstruction is common.

      Phase contrast magnetic resonance imaging can be used to discriminate between communicating
      hydrocephalus and non-communicating hydrocephalus, to localize the level of obstruction in
      obstructive hydrocephalus, to determine whether arachnoid cysts communicate with the
      subarachnoid space, to differentiate between arachnoid cysts and subarachnoid space, to
      discriminate between syringomyelia and cystic myelomalacia, and to evaluate flow patterns of
      posterior fossa cystic malformations.

      This imaging method can also provide significant information in pre-operative evaluation of
      Chiari 1 malformation and post-operative follow-up of patients with neuroendoscopic third
      ventriculostomy and ventriculoperitoneal shunt.

      The application of cine phase contrast magnetic resonance imaging technique in patients with
      normal pressure hydrocephalus holds great promise for improvement of the diagnosis,
      especially in those cases where the differentiation from atrophy on clinical and conventional
      radiological basis is difficult.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 25, 2018</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To calculate different cerebrospinal fluid flow parameters at different levels of flow quantification.</measure>
    <time_frame>base line</time_frame>
    <description>measure Systolic stroke volume and Peak systolic velocity at different levels of flow quantification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To correlate these parameters to the normal values of age matched control group</measure>
    <time_frame>baseline</time_frame>
    <description>correlate Systolic stroke volume and Peak systolic velocity with normal values</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">87</enrollment>
  <condition>Cerebrospinal Fluid</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <description>patients with congenital and acquired disorders that can alter the CSF dynamics will undergo phase-contrast magnetic resonance imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>age matched healthy individuals will undergo phase-contrast magnetic resonance imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic Resonance Imaging</intervention_name>
    <description>Phase contrast magnetic resonance imaging technique</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with different age groups and both sex with clinical and routine conventional
        magnetic resonance imaging findings suggestive of cerebrospinal fluid flow disorders
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with different age groups and both sex with clinical and routine conventional
             magnetic resonance imaging findings suggestive of cerebrospinal fluid flow disorders.

        Exclusion Criteria:

          1. Patients with contraindications for MRI, e.g. an implanted magnetic device, pacemakers
             or claustrophobia.

          2. Patients with VP shunts

          3. Patients with ventriculomegally due to brain SOLs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shimaa Bakr, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mostafa Hussein</last_name>
    <phone>01122999878</phone>
    <email>thabet.mostafa@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hazem Youseif</last_name>
    <phone>01005075888</phone>
    <email>bozaidhazz@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of medicine</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mostafa Thabet, MD</last_name>
      <phone>01122999878</phone>
      <email>thabet.mostafa@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Marwa Ahmed, MD</last_name>
      <phone>01006541595</phone>
      <email>drmarwa201198@ymail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Sakka L, Coll G, Chazal J. Anatomy and physiology of cerebrospinal fluid. Eur Ann Otorhinolaryngol Head Neck Dis. 2011 Dec;128(6):309-16. doi: 10.1016/j.anorl.2011.03.002. Epub 2011 Nov 18. Review.</citation>
    <PMID>22100360</PMID>
  </reference>
  <reference>
    <citation>Yildiz H, Yazici Z, Hakyemez B, Erdogan C, Parlak M. Evaluation of CSF flow patterns of posterior fossa cystic malformations using CSF flow MR imaging. Neuroradiology. 2006 Sep;48(9):595-605. Epub 2006 Jun 3.</citation>
    <PMID>16752134</PMID>
  </reference>
  <reference>
    <citation>Yamada S, Tsuchiya K, Bradley WG, Law M, Winkler ML, Borzage MT, Miyazaki M, Kelly EJ, McComb JG. Current and emerging MR imaging techniques for the diagnosis and management of CSF flow disorders: a review of phase-contrast and time-spatial labeling inversion pulse. AJNR Am J Neuroradiol. 2015 Apr;36(4):623-30. doi: 10.3174/ajnr.A4030. Epub 2014 Jul 10. Review.</citation>
    <PMID>25012672</PMID>
  </reference>
  <reference>
    <citation>Parkkola RK, Komu ME, AÃ¤rimaa TM, Alanen MS, Thomsen C. Cerebrospinal fluid flow in children with normal and dilated ventricles studied by MR imaging. Acta Radiol. 2001 Jan;42(1):33-8.</citation>
    <PMID>11167329</PMID>
  </reference>
  <reference>
    <citation>Ng SE, Low AM, Tang KK, Lim WE, Kwok RK. Idiopathic normal pressure hydrocephalus: correlating magnetic resonance imaging biomarkers with clinical response. Ann Acad Med Singapore. 2009 Sep;38(9):803-8. Review.</citation>
    <PMID>19816640</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>August 29, 2018</study_first_submitted>
  <study_first_submitted_qc>August 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2018</study_first_posted>
  <last_update_submitted>May 27, 2020</last_update_submitted>
  <last_update_submitted_qc>May 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Shimaa Hassanien Hassanien Bakr</investigator_full_name>
    <investigator_title>principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

